Palla Pharma Ltd
ASX:PAL
Palla Pharma Ltd
Net Income (Common)
Palla Pharma Ltd
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Palla Pharma Ltd
ASX:PAL
|
Net Income (Common)
-AU$58.8m
|
CAGR 3-Years
-76%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
N/A
|
|
Anteotech Ltd
ASX:ADO
|
Net Income (Common)
-AU$11.5m
|
CAGR 3-Years
-49%
|
CAGR 5-Years
-37%
|
CAGR 10-Years
-19%
|
|
Proteomics International Laboratories Ltd
ASX:PIQ
|
Net Income (Common)
-AU$5.9m
|
CAGR 3-Years
-35%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
N/A
|
|
Cryosite Ltd
ASX:CTE
|
Net Income (Common)
AU$1.6m
|
CAGR 3-Years
45%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
4%
|
|
Genetic Signatures Ltd
ASX:GSS
|
Net Income (Common)
-AU$18m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-40%
|
CAGR 10-Years
N/A
|
|
E
|
EZZ Life Science Holdings Ltd
ASX:EZZ
|
Net Income (Common)
AU$3.6m
|
CAGR 3-Years
32%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Palla Pharma Ltd's Net Income (Common)?
Net Income (Common)
-58.8m
AUD
Based on the financial report for Jun 30, 2021, Palla Pharma Ltd's Net Income (Common) amounts to -58.8m AUD.
What is Palla Pharma Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
-19%
Over the last year, the Net Income (Common) growth was -368%. The average annual Net Income (Common) growth rates for Palla Pharma Ltd have been -76% over the past three years , -19% over the past five years .